2026 NPPES data Hematology & Oncology Physician NPI 1184044927
Verify on CMS →

YELENA PRISTYAZHNYUK

Hematology & Oncology Physician in HARTFORD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
351
Medicare Part D claims · 48 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
65%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
86.4127/100
▲ 3 pts above national avg 83.1 · [object Object]
Industry payments
$8.9K
4 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

YELENA PRISTYAZHNYUK reported a CMS MIPS final score of 86.4127/100 — above the 83.1 national average — and filed 351 Medicare Part D claims in 2023.

86.4127/100
MIPS score · +3 vs avg
351
Part D claims, 2023
65%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

YELENA PRISTYAZHNYUK's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

86 Top 48% higher than 52% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

YELENA PRISTYAZHNYUK practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about YELENA PRISTYAZHNYUK?

High performer (top quartile)

NPI registry status

Active

Issued 04/20/2014

NPI 1184044927

Primary specialty

Hematology & Oncology Physician

Mid-sized

11,215 US NPIs in this specialty

Medicare Part D claims

351 59% vs specialty avg

2023 prescription claims

Specialty avg: 847

MIPS final score

86.4127/100 3.3127000000000066% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Connecticut

How Hematology & Oncology Physician compares to other specialties among Connecticut providers

Connecticut providers

Hematology & Oncology Physician share within Connecticut

1. Hematology & Oncology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Hematology & Oncology Physician share within Connecticut

Medicare quality performance — MIPS

YELENA PRISTYAZHNYUK's 2023 MIPS final score plotted against the Hematology & Oncology Physician national average

High performer (top quartile)
MIPS Final Score
86.4127/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Hematology & Oncology Physician) — 86.4127/100 vs national avg 83.1

0%100%National avg83%86.4%
MIPS final score (Hematology & Oncology Physician) — 86.4127/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

YELENA PRISTYAZHNYUK is a Hematology & Oncology Physician provider practicing in HARTFORD, Connecticut, according to the CMS National Plan and Provider Enumeration System (NPPES). NPI: 1184044927. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

YELENA PRISTYAZHNYUK appears in the CMS NPPES registry as a Hematology & Oncology Physician provider at HHC CANCER INSTITUTE AT HARTFORD HOSPITAL, HARTFORD, CT, 06106, with a listed phone of (860) 249-6291. NPI 1184044927 was issued on 04/20/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what PRISTYAZHNYUK most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 351 prescription claims written by this provider, covering 48 Medicare beneficiaries and totaling roughly $1.2 million in drug spend, split 35% brand-name and 65% generic by claim count, with an opioid prescribing rate of 3.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 86.4127/100 for the 2023 performance year (Quality 81.9936, Cost 43.0396), compared with the national average of 83.1.

Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

HHC CANCER INSTITUTE AT HARTFORD HOSPITAL
HARTFORD, CT 06106

Provider Details

NPI 1184044927
Specialty Hematology & Oncology Physician
Gender Female
NPI Issued 04/20/2014

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

86.4127
Final Score
Avg: 83.1
81.9936
Quality
43.0396
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where YELENA PRISTYAZHNYUK bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

HARTFORD HOSPITAL
★★★★☆ 4/5
HARTFORD, CT
Acute Care Hospitals
CMS CCN: 070025

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for YELENA PRISTYAZHNYUK. Source: openpaymentsdata.cms.gov.

Total received

$8.9K

Largest payer

Takeda Pharmaceuticals U.S.A., Inc.

Most common payment type

Travel and Lodging

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Above average

YELENA PRISTYAZHNYUK — brand share 35.0%
Specialty average (est.)

35% brand-name claims vs 65% generic, on 351 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

351
Total Claims
$1.2M
Total Drug Cost
48
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
470
Total Day Supply
12,271
Brand vs Generic
35% brand / 65% generic
Brand Drug Cost
$1.1M
Generic Drug Cost
$136K
Opioid Claims
12 (3.4% rate)
Antibiotic Claims
18

Patient Demographics

Average Patient Age
70.8 years
Avg HCC Risk Score
2.77
Gender Split
58% female / 42% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Acyclovir
42
Eliquis
Apixaban
22
Revlimid
Lenalidomide
21
Prednisone
19
Brukinsa
Zanubrutinib
13
Venclexta
Venetoclax
13
Dexamethasone
11
Gabapentin
11
Lenalidomide
11
Sprycel
Dasatinib
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Hematology & Oncology Physician Overview

How YELENA PRISTYAZHNYUK fits within the Hematology & Oncology Physician landscape nationally.

11,215
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider

YELENA PRISTYAZHNYUK's 351 claims are below the specialty average of 847.

Nearby Hematology & Oncology Physician Providers in Connecticut

Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as PRISTYAZHNYUK.

Compare Hematology & Oncology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is YELENA PRISTYAZHNYUK's specialty?
YELENA PRISTYAZHNYUK specializes in Hematology & Oncology Physician and practices in HARTFORD, Connecticut.
How much does YELENA PRISTYAZHNYUK prescribe under Medicare Part D?
In 2023, YELENA PRISTYAZHNYUK wrote 351 Medicare Part D claims totaling $1.2M in drug costs for 48 beneficiaries.
What is YELENA PRISTYAZHNYUK's Medicare quality score?
YELENA PRISTYAZHNYUK has a CMS MIPS Final Score of 86.4127/100 (Quality: 81.9936, Cost: 43.0396). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is YELENA PRISTYAZHNYUK located?
YELENA PRISTYAZHNYUK is located at HHC CANCER INSTITUTE AT HARTFORD HOSPITAL, HARTFORD, CT, 06106. Phone: (860) 249-6291.
What is YELENA PRISTYAZHNYUK's NPI number?
YELENA PRISTYAZHNYUK's National Provider Identifier (NPI) is 1184044927, issued on 04/20/2014.
Does YELENA PRISTYAZHNYUK prescribe more brand-name or generic drugs?
YELENA PRISTYAZHNYUK's prescribing is 35% brand-name and 65% generic drugs by claim count, with $1.1M in brand drug costs.
Does YELENA PRISTYAZHNYUK prescribe opioids?
Yes, YELENA PRISTYAZHNYUK had 12 opioid claims in 2023 with an opioid prescribing rate of 3.4%.
How many Hematology & Oncology Physician providers are there in the US?
There are 11,215 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does YELENA PRISTYAZHNYUK prescribe most often?
Based on 2023 Medicare Part D data, YELENA PRISTYAZHNYUK's most frequently prescribed drugs include Acyclovir, Eliquis, Revlimid. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does YELENA PRISTYAZHNYUK accept Medicare?
YELENA PRISTYAZHNYUK appears in CMS Medicare data with 351 Part D claims and 48 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify YELENA PRISTYAZHNYUK's credentials?
YELENA PRISTYAZHNYUK's NPI is 1184044927. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology